Bayer Announces Leadership Change Within Pharmaceuticals' Worldwide Markets Organization in the U.S. to Support Company's Full Growth Potential

Core Viewpoint - Bayer is implementing a leadership change in its Pharmaceuticals' Worldwide Markets organization to enhance the performance and growth of its pharmaceutical products in the U.S. [1] Group 1: Leadership Change - Effective May 1, 2026, Nelson Ambrogio will be appointed as President of Bayer U.S. Pharmaceuticals [1] - Ambrogio is currently the President of Bayer's global Radiology business [1] - The leadership change aims to guide the U.S. Pharmaceuticals organization into a new growth phase [1]